CD44 and breast carcinoma: Thus, the first report demonstrating that CTL can recognize and eliminate CSC populations was using CSC-enriched MCF-7 breast cancer and SK-OV-3 ovarian cancer cells (CD44+/CD24lo/CD133+) after treatment with 5-fluorouracil and paclitaxel.